Epidemiology of sepsis: An update

Critical Care Medicine

Volumn 29, Issue 7 SUPPL., 2001, Pages

  Angus, D C ^a   Wax, R S ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Genetic polymorphism; Intensive care; Methods; Outcome; Predictive models; Randomized trials; Scoring systems; Sepsis; Septic shock; Severe sepsis

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

CONFERENCE PAPER; DISEASE SEVERITY; FEMALE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; HOSPITAL ADMISSION; HUMAN; INCIDENCE; INFECTION RISK; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM; SEPSIS; SEPTIC SHOCK; TREATMENT OUTCOME;

EID: 0034924156     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200107001-00035     Document Type: Conference Paper

References (48)

1. The sepsis syndrome in a Dutch university hospital: Clinical observations
2. Assessment of the safety and efficacy of the monoclonal anti-tumor necrosis factor antibody-fragment, MAK 195F, in patients with sepsis and septic shock: A multicenter, randomized, placebo-controlled, dose-ranging study
3. Bedside prediction of mortality from bacteremic sepsis: A dynamic analysis of ICU patients
4. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis: The ACCP/SCCM Consensus Conference Committee
5. Dear SIRS, I'm sorry to say that I don't like you
6. Evaluation of definitions for sepsis
7. Increase in national hospital discharge survey rates for septicemia: United States, 1979-1987
8. The natural history of the systemic inflammatory response syndrome (SIRS): A prospective study
9. Epidemiology of sepsis syndrome in 8 academic medical centers: Academic Medical Center Consortium Sepsis Project Working Group
10. Incidence, risk factors, and outcome of severe sepsis and septic shock in adults: A multicenter prospective study in intensive care units
11. The Italian SEPSIS study: Preliminary results on the incidence and evolution of SIRS, sepsis, severe sepsis and septic shock
12. Sepsis and SIRS: Are we any nearer to consensus?
13. Has the mortality of septic shock changed with time
14. Reduced mortality from septic shock: Lessons for the future
15. An overview of mortality risk prediction in sepsis
16. The epidemiology of bacterial sepsis
17. Clinical Gram-positive sepsis: Does it fundamentally differ from Gram-negative bacterial sepsis?
18. Nosocomial bacteremia in a medical-surgical intensive care unit: Epidemiologic characteristics and factors influencing mortality in 111 episodes
19. A prospective study of the use of a dobutamine stress test to identify outcome in patients with sepsis, severe sepsis, or septic shock
20. The dobutamine oxygen flux test: A road map to outcome in sepsis?
21. Long-term survival and function after suspected gram-negative sepsis
22. Long-term survival after intensive care unit admission with sepsis
23. The clinical evaluation of new drugs for sepsis: A prospective study design based on survival analysis
24. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome
25. High circulating levels of interleukin-6 in patients with septic shock: Evolution during sepsis, prognostic value, and interplay with other cytokines; The Swiss-Dutch J5 Immunoglobulin Study Group
26. Serum cytokine levels in human septic shock: Relation to multiple-system organ failure and mortality
27. Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans
28. Plasma tumor necrosis factor in patients with septic shock: Mortality rate, incidence of adult respiratory distress syndrome, and effects of methylprednisolone administration
29. Variation in the tumor necrosis factor-α gene promoter region may be associated with death from meningococcal disease
30. -308 Tumor necrosis factor (TNF) polymorphism is not associated with survival in severe sepsis and is unrelated to lipopolysaccharide inducibility of the human TNF promoter
31. A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-α concentrations and outcome of patients with severe sepsis
32. Analysis of two human leukocyte antigen-linked polymorphic heat shock protein 70 genes in patients with severe sepsis
33. Comparison of two polymorphisms of the interleukin-1 gene family: Interleukin-1 receptor antagonist polymorphism contributes to susceptibility to severe sepsis
34. Relation of a TNF gene polymorphism to severe sepsis in trauma patients
35. Association of TNF2, a TNF-α promoter polymorphism, with septic shock susceptibility and mortality: A multicenter study
36. The molecular genetics of sepsis: Clinical epidemiology considerations
37. Quantifying risk in sepsis: A review of illness severity and organ dysfunction scoring
38. Effect of gender and sex hormones on immune responses following shock
39. Gender-related therapy: Early IL-10 administration after hemorrhage restores immune function in males but not in females
40. Incidence and mortality of severe sepsis in surgical intensive care patients: The influence of patient gender on disease process and outcome
41. Gender differences in sepsis: Genetically determined?
42. Discourse on method: Measuring the value of new therapies in intensive care
43. Septic shock: An analysis of outcomes for patients with onset on hospital wards versus intensive care units
44. Customized probability models for early severe sepsis in adult intensive care patients: Intensive Care Unit Scoring Group
45. Use of predicted risk of mortality to evaluate the efficacy of anticytokine therapy in sepsis: The rhIL-1ra Phase III Sepsis Syndrome Study Group
46. Community-acquired pneumonia: Epidemiology, etiology, treatment
47. Age-specific incidence and outcome of sepsis in the US